PHARMACOKINETIC, TOLERABILITY AND SAFETY PROFILE OF SA001 TABLET, A NOVEL ORAL TREATMENT FOR DRY EYE SYNDROME, AFTER SINGLE ADMINISTRATIONS IN HEALTHY SUBJECTS.

被引：0
|
作者：
Kim, Y. [1 ]
Oh, J. [1 ]
Kim, A. [2 ]
Kim, E. [1 ]
Yoo, H. [1 ]
Yoon, S. [3 ]
Lee, S. [1 ]
Yu, K. -S. [1 ]
机构：
[1] Seoul Natl Univ, Coll Med & Hosp, Dept Clin Pharmacol & Therapeut, Seoul, South Korea
[2] Ajou Univ, Clin Trial Ctr, Med Ctr, Suwon, South Korea
[3] Seoul Natl Univ, Bundang Hosp, Clin Trials Ctr, Seongnam, South Korea
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2018年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PI-008
引用
收藏
页码：S17 / S17
页数：1
相关论文
共 18 条
  • [1] PHARMACOKINETIC, TOLERABILITY AND SAFETY PROFILES OF SA001 TABLET, A NOVEL ORAL TREATMENT FOR DRY EYE SYNDROME, AFTER MULTIPLE ADMINISTRATIONS IN HEALTHY SUBJECTS.
    Kim, Y.
    Oh, J.
    Kim, A.
    Kim, E.
    Yoo, H.
    Yoon, S.
    Lee, S.
    Yu, K-S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S17 - S17
  • [2] Evaluation of Safety, Tolerability and Pharmacokinetic Characteristics of SA001 and Its Active Metabolite Rebamipide after Single and Multiple Oral Administration
    Bae, Sungyeun
    Huh, Ki Young
    Oh, Jaeseong
    Yu, Kyung-Sang
    Kim, Anhye
    PHARMACEUTICALS, 2023, 16 (01)
  • [3] Pharmacokinetic and safety profile of olmesartan medoxomil in healthy Chinese subjects after single and multiple administrations
    Jiang, Ji
    Liu, Dongyang
    Hu, Pei
    PHARMAZIE, 2009, 64 (05): : 323 - 326
  • [4] PHARMACOKINETICS, SAFETY AND TOLERABILITY OF VALBENAZINE AFTER SINGLE AND MULTIPLE ORAL ADMINISTRATION IN HEALTHY KOREAN MALE SUBJECTS.
    Chung, W.
    Huh, K.
    Ka, J.
    Bae, S.
    Oh, J.
    Yoon, S.
    Jang, I.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S15 - S15
  • [5] Pharmacokinetics, safety and tolerability of L-3-ν-butylphthalide tablet after single and multiple oral administrations in healthy Chinese volunteers
    Wang, Meng
    Zhang, Quan-ying
    Hua, Wen-yan
    Huang, Ming
    Zhou, Wen-jia
    Lou, Kun
    Peng, Yue-ying
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 51 (03) : 525 - 531
  • [6] Safety, Tolerability and Pharmacokinetic Profile of Single and Multiple Oral Doses of Arterolane ( RBx11160) Maleate in Healthy Subjects
    Saha, Nilanjan
    Moehrle, Joerg J.
    Zutshi, Anita
    Sharma, Pradeep
    Kaur, Pawandeep
    Iyer, Sunil S.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (04): : 386 - 393
  • [7] Safety and tolerability of SCH 530348, a novel antiplatelet agent, after single and multiple oral dosing in healthy subjects
    Kosoglou, T.
    Tiessen, R.
    Van Vliet, A. A.
    Fales, R. R.
    Keller, R.
    Cutler, D. L.
    EUROPEAN HEART JOURNAL, 2008, 29 : 201 - 201
  • [8] Comparison of the Safety, Tolerability, and Pharmacokinetic Profile of a Single Oral Dose of Pitavastatin 4 mg in Adult Subjects With Severe Renal Impairment Not on Hemodialysis Versus Healthy Adult Subjects
    Morgan, Roger E.
    Campbell, Stuart E.
    Yu, Christine Y.
    Sponseller, Craig A.
    Muster, Heather A.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2012, 60 (01) : 42 - 48
  • [9] PHARMACOKINETICS, PHARMACODYNAMICS AND TOLERABILITY OF JP-1366, A NOVEL POTASSIUM-COMPETITIVE ACID BLOCKER, AFTER A SINGLE ORAL DOSE IN HEALTHY SUBJECTS.
    Kim, J.
    Jin, X.
    Hwang, I.
    Oh, J.
    Kim, J.
    Park, J.
    Heo, J.
    Lee, Y.
    Jang, I. -J.
    Chung, J. -Y.
    Lee, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S101 - S101
  • [10] Safety, tolerability, pharmacokinetic profile and pharmacodynamic characteristics of sabiporide, a novel cardioselective NHE-inhibitor, after oral and IV single doses in healthy male volunteers.
    Klueglich, M
    Rathgen, K
    Nehmiz, G
    Trommeshauser, D
    Seidler, R
    Rathgen, K
    Nehmiz, G
    Trommeshauser, D
    Seidler, R
    Roberts, J
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (09): : 1056 - 1056
12